paediatric clinical development
Minimising the Risk of Regulatory Censure
June 01 by Pharma IQDr. Philippe Auby Senior Medical Director, Corporate ICR France & Paediatrics, Lundbeck joins Pharma IQ to share his insights on minimising the risk of regulatory censure in paediatric...
Preparing and Submitting Robust Paediatric Investigation Plans
May 20 by Pharma IQPharma IQ held a Q&A session with Karl-Heinz Huemer, PDCO Member and Clinical Assessor, Austrian Medicines Agency to gain a few insights into preparing and submitting robust PIPs... T...
